精品人妻少妇一级毛片免费-国产成人视频在线观看-成人精品一区二区三区四区-久久成人免费视频

E-mail      中文 | ENGLISH
Location:Home > Products > Product Description
Products

CARTISTEM

1) CARTISTEM, the Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell drug developed by Medipost; One of the ten stem cell drugs in the world.
2) It has been approved of its commercial use by the Ministry of Food & Drug Safety in January 2012. Become the first stem cell drug for the treatment of knee osteoarthritis, breaking the traditional concept of cartilage cannot be regenerate.
3) Dosage Form: a suspension of hUCB-MSC in hyaluronic acid (gel matrix)

  • Stem Cell
  • Indications
  • Treatment Principles
  • Product Advantages
  • Populations Applicable

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. They are found in multicellular organisms. In mammals, there are two broad types of stem cells: embryonic stem cells, which are isolated from the inner cell mass of blastocysts, and adult stem cells, which are found in various tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing adult tissues.

IndicationRepair of knee cartilage defects in patients with osteoarthritis (ICRS grade IV) as a result of degeneration or repetitive trauma.



hUCB-MSCs transplanted into damaged cartilage were stimulated by unknown injury factors in the SF from OA patients to increased TSP-2 secretion. This TSP-2 diffused into synovial cavity and induced differentiation of chondroprogenitor cells. By means of this paracrine action of at least TSP-2, hUCB-MSCs accomplishes regeneration of damaged cartilage.





Advantages:

1. Sole stem cell drug has been approved of its commercial use in arthritis in the world

2. Not subject to age restriction, only one operation can be cured

3. Sustained and excellent support for the regenerate cartilage within 7 years

4.The results of the Phase III clinical trial showed a effective rate of 97.7%

5. Small surgical trauma, Remarkable curative effect for large area of cartilage damage

6. Simple operation procedure and short hospitalization time 



      



The target patient of CARTISTEM is the person with ICRS IV Ocaused by repeated trauma or degenerative. CARTISTEM is the first treatment option for severe OA patients in the age group between 50s and 60s at the moment. On the other hand, the target patient without limitation by age. By far, the youngest patient was at the age of 12 and the oldest was at the age of 94. 

                                                                                                                


2020亚洲天堂 | 日本一级婬A片免费看 | 无码人妻精品一区二区三18禁 | 水蜜桃在线观看免费视频 | 国产人妻精品一二三区 | 香蕉视频一区二区 | 強姧伦一区二区三区在线播放 | 亚洲精品成人18久久久久 | 免费一级婬片AA片在线播放口述 | 亚洲午夜免费视频 | 日韩A片无码毛片免费看小说 | 亚洲国产AV一区二区 | 欧美成人a交片免费看 | 一级视频在线观看免费 | 久久人人搡人妻人人玩夜色av | 国精产品一区二区免费 | 午夜高清无码在线 | 成人无码欧美一级激情A | 91精品人妻人人做 | 极品国产 白质爆乳 | 性色av一区二区三区 | 无码人妻一区二区三区免费看视频 | 北京熟妇ThePorn | 丰满岳乱妇一级A片 | 国产成人无码www免费视频在线观看 | 精品少妇人妻av无码中文字幕 | 污污视频在线免费观看 | AV动漫在线观看 | 成人无码视频又粗又硬视频 | 国产精品久久久久无码 | 国产午夜三级一区二区三 | 91精品国产乱码久久久久久久久 | 久久精品免费观看 | 亚洲熟妇高潮一区 | 四虎影国产精品永久地址49 | 亚洲AV无码专区国产精品色欲 | 亚洲无码一区二区三区三州 | 91人妻人人澡人人爽人人精吕 | 69久久夜色精品国产69柘城县 | 日本乱婬一区二区三区 | 亚欧三级视频在线观看 |